Moderna's Stock Surges on Biotech Sector Boost

Modernas stock surged by four percent in afternoon trading, buoyed by a sector-wide rebound in biotechnology. Factors driving this growth include promising clinical data, successful new medication launches, and increased merger and acquisition activity. Modernas upcoming presentation at the J.P. Morgan Healthcare Conference further boosted sentiment. However, the stocks volatility and recent decline suggest a temporary positive sentiment rather than a fundamental shift.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.